Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine

Maïté Verreault(BC Cancer Agency), Donald T. Yapp(BC Cancer Agency)

BMC Cancer

April 8, 2011

10.1186/1471-2407-11-124

Cited by 56

Related Papers

Combined RNAi-Mediated Suppression of Rictor and EGFR Resulted in Complete Tumor Regression in an Orthotopic Glioblastoma Tumor Model

|PLoS ONE|2013|28

Overexpression of HER-2 in MDA-MB-435/LCC6 Tumours is Associated with Higher Metabolic Activity and Lower Energy Stress

|Scientific Reports|2016|1